Back to search

Peptide record

TPDB05835

Antibacterial standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05835
Antibacterial
Anti-infective peptides
AntiBP3 Peptipedia
standard
No
A 9-aa standard-residue antibacterial peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
RWRRWKWWL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C74H101N23O10
ANDCEQGHIMFPSTYV
W
1472.76
12.71
4
0
5
+4
4.01
-1.911
43.33
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
22000
14.94
0
Residue Composition
number
0
A
3
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
1
L
1
K
0
M
0
F
0
P
0
S
0
T
4
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 1 K: 1 M: 0 F: 0 P: 0 S: 0 T: 0 W: 4 Y: 0 V: 0
Chemical Descriptors
9 reviewed residue count
C74H101N23O10 sequence-only estimate (linear, free termini)
1472.76 sequence-only estimate (linear, free termini)
12.71 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
4.01 sequence-only estimate (linear, free termini)
-1.911 sequence-only estimate (linear, free termini)
Evidence Records 6 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.3-37 µM

Target

Pseudomonas aeruginosa PAO1 or WT or resistant strains

Source & Reference

NA

Other

active against 6 P. aeruginosa PAO1 or WT or resistant strains (MIC 0.3-37 uM), E. cloacae Strain C601 (MIC 6 uM), E. coli ESBL (MIC 3 uM), K. pneumoniae (MIC 11 uM), S
Evidence 2 Activity

Activity

MIC
Antibacterial
6 µM

Target

Enterobacter cloacae Strain C601

Source & Reference

NA

Other

active against 6 P. aeruginosa PAO1 or WT or resistant strains (MIC 0.3-37 uM), E. cloacae Strain C601 (MIC 6 uM), E. coli ESBL (MIC 3 uM), K. pneumoniae (MIC 11 uM), S. aureus ATCC 25923 or MRSA (MIC 3
Evidence 3 Activity

Activity

MIC
Antibacterial
3 µM

Target

Escherichia coli ESBL

Source & Reference

NA

Other

inosa PAO1 or WT or resistant strains (MIC 0.3-37 uM), E. cloacae Strain C601 (MIC 6 uM), E. coli ESBL (MIC 3 uM), K. pneumoniae (MIC 11 uM), S. aureus ATCC 25923 or MRSA (MIC 3 uM), 5 E. faecalis ATCC29
Evidence 4 Activity

Activity

MIC
Antibacterial
11 µM

Target

Klebsiella pneumoniae

Source & Reference

NA

Other

tant strains (MIC 0.3-37 uM), E. cloacae Strain C601 (MIC 6 uM), E. coli ESBL (MIC 3 uM), K. pneumoniae (MIC 11 uM), S. aureus ATCC 25923 or MRSA (MIC 3 uM), 5 E. faecalis ATCC29212 (MIC 1.4-92 uM) anti-VR
Evidence 5 Activity

Activity

MIC
Antibacterial
3 µM

Target

Staphylococcus aureus ATCC 25923 or MRSA

Source & Reference

NA

Other

), E. cloacae Strain C601 (MIC 6 uM), E. coli ESBL (MIC 3 uM), K. pneumoniae (MIC 11 uM), S. aureus ATCC 25923 or MRSA (MIC 3 uM), 5 E. faecalis ATCC29212 (MIC 1.4-92 uM) anti-VRE.
Evidence 6 Activity

Activity

MIC
Antibacterial
1.4-92 µM

Target

Enterococcus faecalis ATCC29212

Source & Reference

NA

Other

li ESBL (MIC 3 uM), K. pneumoniae (MIC 11 uM), S. aureus ATCC 25923 or MRSA (MIC 3 uM), 5 E. faecalis ATCC29212 (MIC 1.4-92 uM) anti-VRE.